Showing results (321-330 of 400) with videos related to
Sort By:
Pageof 40
Leukemia|March 23, 2023
Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy resultsMichael J Mauro, Timothy P Hughes, Dong-Wook Kim, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 16, 2024
Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in OncologyBijal Shah, Ryan J Mattison, Ramzi Abboud, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2020
Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyMichael W Deininger, Neil P Shah, Jessica K Altman, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2019Patrick A Brown, Matthew Wieduwilt, Aaron Logan, et al.Nature Cancer|September 22, 2022
Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypesSatyaki Sengupta, Sanjukta Das, Angela C Crespo, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 10, 2012
Acute lymphoblastic leukemiaJoseph C Alvarnas, Patrick A Brown, Patricia Aoun, et al.Cancer Discovery|August 17, 2019
Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung CancerAnna F Farago, Beow Y Yeap, Marcello Stanzione, et al.Cancer Immunology Research|November 19, 2016
Cytotoxic T Cells in PD-L1-Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive FactorsMark M Awad, Robert E Jones, Hongye Liu, et al.Nature Communications|May 2, 2026
PTPN2 inhibition unleashes response to STING agonism in head and neck squamous cell cancerZehua Li, Cong Fu, Kartik Sehgal, et al.Cancer Cell|September 23, 2022
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancerShunsuke Kitajima, Tetsuo Tani, Benjamin F Springer, et al.Pageof 40